MedTrace Logo

Effectiveness of an Air Purifier on Asthmatic and Cat-allergic Subjects in the ALYATEC Environmental Exposure Chamber

NCT06691568 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-11-15

No results posted yet for this study

Summary

The goal of this clinical trial is to evaluate the efficacy of air purifiers in reducing allergy symptoms in patients with a cat allergy. The main question it aims to answer is:

If there is a reduction of early asthmatic response (EAR) compared to placebo.

Participants were asked to remain in an exposure chamber for 2 hours while their symptoms were monitored.

Conditions

  • Cat Allergy

Interventions

DEVICE

Air purifier

Purifiers were turned on for the active group and off for the placebo

Sponsors & Collaborators

  • Alyatec

    collaborator INDUSTRY

  • Dyson Technology Ltd

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-20
Primary Completion
2023-10-26
Completion
2023-10-26

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06691568 on ClinicalTrials.gov